Intestinal permeability-A prognostic indicator in ovarian cancer?

Journal of Clinical Gastroenterology

Volumn 42, Issue 6, 2008, Pages 759-760

  Melichar, Bohuslav ^a   Hyšpler, Radomír ^a   Dragounová, Emanuela ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

LACTULOSE; MANNITOL; SUCROSE; XYLOSE;

ADVANCED CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CAPILLARY GAS CHROMATOGRAPHY; COLORECTAL CARCINOMA; GALLBLADDER CARCINOMA; GASTROINTESTINAL TOXICITY; HUMAN; INTESTINE MUCOSA PERMEABILITY; LABORATORY TEST; LETTER; OVARY CANCER; PERITONEUM PSEUDOMYXOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; URINARY EXCRETION; CLINICAL TRIAL; FEMALE; FOLLOW UP; INTESTINE ABSORPTION; METASTASIS; OVARY TUMOR; PATHOLOGY; PERMEABILITY; SURVIVAL RATE;

FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL ABSORPTION; OVARIAN NEOPLASMS; PERMEABILITY; PROGNOSIS; SURVIVAL RATE;

EID: 54649084151     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318032bebf     Document Type: Letter

References (9)

1. Piccart MJ, Bertelsen K, James K, et al. Randomized Intergroup trial of cisplatinpaclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J Natl Cancer Inst. 2000;92:699-708.
2. DeMeo MT, Mutlu EA, Keshavarzian A, et al. Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol. 2002;34:385-396.
3. Melichar B, Dvorak J, Hyspler R, et al. Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents. Chemotherapy. 2005;51:336-338.
4. Cibickova L, Cibicek N, Zdansky P, et al. The impairment of gastroduodenal mucosal barrier by coffee. Acta Medica (Hradec Kralove). 2004;47:273-276.
5. Parrilli G, Iaffaioli RV, Martorano M, et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res. 1989;49:3689-3691.
6. Sundstrom GM, Wahlin A, Nordin-Anderson I, et al. Intestinal permeability in patients with acute myeloid leukemia. Eur J Haematol. 1998;61:250-254.
7. van der Hulst RRWJ, von Meyenfeldt MF, van Kreel BK, et al. Gut permeability, intestinal morphology, and nutritional depletion. Nutrition. 1998;14:1-6.
8. Clark TG, Stewart ME, Altman DG, et al. A prognostic model for ovarian cancer. Br J Cancer. 2001;85:944-952.
9. Melichar B, Solichová D, Freedman RS. Neopterin as an indicator of immune activation and prognosis in patients with gynecological malignancies. Int J Gynecol Cancer. 2006;16:240-252.